NFL Biosciences SA (EPA:ALNFL)
1.046
+0.006 (0.58%)
Apr 28, 2026, 5:14 PM CET
NFL Biosciences Revenue
In the year 2025, NFL Biosciences had annual revenue of 188.00 EUR with 308.70% growth. NFL Biosciences had revenue of 15.00 in the half year ending December 31, 2025, with 400.00% growth.
Revenue
188.00
Revenue Growth
+308.70%
P/S Ratio
70,506.20
Revenue / Employee
37.60
Employees
5
Market Cap
13.26M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Poxel | 7.66M |
| Aelis Farma | 2.33M |
| Advicenne | 5.90M |
| Aton | 656.93K |
| GenSight Biologics | 652.00K |
| Oncodesign Precision Medicine Société anonyme | 1.74M |
| Plant Advanced Technologies | 2.22M |
| genOway Société anonyme | 20.96M |